Invention Grant
- Patent Title: Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
-
Application No.: US14284524Application Date: 2014-05-22
-
Publication No.: US09457038B2Publication Date: 2016-10-04
- Inventor: Alexandre Kaoukhov , Christophe Villard , Philippe Bouissou
- Applicant: Galderma S.A.
- Applicant Address: CH Cham
- Assignee: GALDERMA S.A.
- Current Assignee: GALDERMA S.A.
- Current Assignee Address: CH Cham
- Agency: Dentons US LLP
- Priority: FR0510025 20050930
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K9/06 ; A61P27/02 ; A61K9/00
Abstract:
Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
Public/Granted literature
- US20140256662A1 ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES Public/Granted day:2014-09-11
Information query
